+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Precipitation of amphotericin B from i.v. fat emulsion

Precipitation of amphotericin B from i.v. fat emulsion

American Journal of Health-System Pharmacy 54(12): 1449-1449

The possibility of insufficient drug delivery when using amphotericin B prepared in fat emulsion is discussed. When the compatibility of amphotericin B with fat emulsion was examined by measuring interfacial tesion, a problem with precipitation was found with the mixture 15 minutes after preparation.

(PDF 0-2 workdays service: $29.90)

Accession: 003237834

Download citation: RISBibTeXText

PMID: 9194992

Related references

Amphotericin B/emulsion admixture interactions: an approach concerning the reduction of amphotericin B toxicity. Journal of Pharmaceutical Sciences 91(11): 2354-2366, 2002

Amphotericin B--fat emulsion in treatment of visceral leishmaniasis--a cost effective substitute for liposomal amphotericin B. Journal of the Indian Medical Association 108(1): 27-28, 2010

Comparison of the toxicity of amphotericin B in 5% dextrose with that of amphotericin B in fat emulsion in a randomized trial with cancer patients. Antimicrobial Agents and ChemoTherapy 43(6): 1445-1448, 1999

Case-control study of amphotericin B in a triglyceride fat emulsion versus conventional amphotericin B in patients with AIDS. PharmacoTherapy 18(5): 1087-1092, 1998

Successful treatment of resistant cryptococcal meningitis with amphotericin B lipid emulsion after nephrotoxicity with conventional intravenous amphotericin B. Journal of Infection 28(3): 319-322, 1994

Pharmacological parameters of intravenously administered amphotericin B in rats: comparison of the conventional formulation with amphotericin B associated with a triglyceride-rich emulsion. Journal of Antimicrobial ChemoTherapy 44(1): 77-84, 1999

Amphotericin B in children with malignant disease: a comparison of the toxicities and pharmacokinetics of amphotericin B administered in dextrose versus lipid emulsion. Antimicrobial Agents and ChemoTherapy 43(6): 1417-1423, 1999

Toxicity and efficacy of conventional amphotericin B deoxycholate versus escalating doses of amphotericin B deoxycholate---fat emulsion in HIV-infected patients with oral candidosis. Clinical Microbiology and Infection 3(4): 455-461, 1997

Amphotericin B in fat emulsion. American Journal of Health-System Pharmacy 53(22): 2701-2701, 1996

Amphotericin B does not mix with fat emulsion. American Journal of Health-System Pharmacy 52(13): 1463-1464, 1995

Amphotericin less toxic in fat emulsion. Nursing Standard 1987) 7(7): 17-17, 1992

Stability of amphotericin B 0.05 and 0.5 mg/mL in 20% fat emulsion. American Journal of Health-System Pharmacy 54(6): 683-686, 1997

Toxicity of amphotericin B emulsion formulations. Journal of Antimicrobial ChemoTherapy 31(5): 806-808, 1993

Stability of an amphotericin b emulsion formulation. Journal of Pharmacy & Pharmacology 43(SUPPL): ABSTACT 93P, 1991